Summary
GlobalData's clinical trial report, “Von Hippel-Lindau Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Von Hippel-Lindau Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Von Hippel-Lindau Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Peloton Therapeutics Inc
Novartis AG
F. Hoffmann-La Roche Ltd
Spaulding Clinical Research LLC
Pfizer Inc
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Von Hippel-Lindau Syndrome to Genetic Disorders Clinical Trials 12
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Von Hippel-Lindau Syndrome Therapeutics Clinical Trials 23
Prominent Drugs 24
Clinical Trial Profile Snapshots 25
Appendix 42
Abbreviations 42
Definitions 42
Research Methodology 43
Secondary Research 43
About GlobalData 43
Contact Us 44
Source 44
List of Tables
Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials by Region, 2018* 7
Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 10
Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2018* 11
Proportion of Von Hippel-Lindau Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2018* 13
Von Hippel-Lindau Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14
Von Hippel-Lindau Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15
Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials by Phase, 2018* 16
Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 17
Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 18
Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 19
Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 20
Von Hippel-Lindau Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 21
Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22
Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 23
Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 24
List of Figures
Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 10
Proportion of Von Hippel-Lindau Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2018* 12
Von Hippel-Lindau Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14
Von Hippel-Lindau Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15
Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2018* 16
Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 17
Von Hippel-Lindau Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 18
Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 19
Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 20
Von Hippel-Lindau Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 21
Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22
Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 23
Von Hippel-Lindau Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 24
GlobalData Methodology 43
